Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Matthew Simon Squires
Introduction
Matthew Simon Squires is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of cancer treatment through his innovative work. His research focuses on the development of combinations of pyrazole kinase inhibitors, which have the potential to enhance the efficacy of cancer therapies.
Latest Patents
Matthew Squires holds a patent for "Combinations of pyrazole kinase inhibitors." This invention provides a combination comprising a cytotoxic compound, a signaling inhibitor, an ancillary agent, or two or more further anti-cancer agents, along with a compound having a specific formula or its derivatives. This patent represents a significant advancement in the fight against cancer, showcasing his commitment to improving patient outcomes.
Career Highlights
Matthew is currently associated with Astex Therapeutics Limited, where he continues to work on groundbreaking research in oncology. His role at the company allows him to collaborate with other experts in the field and contribute to the development of innovative cancer treatments.
Collaborations
Matthew has worked alongside talented colleagues, including Jayne Elizabeth Curry and John Francis Lyons. Their combined expertise fosters a collaborative environment that enhances the research and development process.
Conclusion
Matthew Simon Squires is a dedicated inventor whose work in the field of cancer treatment is making a significant impact. His innovative patent and collaboration with esteemed colleagues highlight his commitment to advancing medical science.